INSIDER · CIK 1304395
Bitterman Robert J
Chairman, Pres. & CEO, Director at Phio Pharmaceuticals Corp. (PHIO)
↗4 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$13KBought on the market
$0.00Sold on the market
1Companies
Sep 29, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 29, 202616:01 | Sep 28, 2026 | PHIOPhio Pharmaceuticals Corp. | Chairman, Pres. & CEO, Director | A · Grant | — | +400,000 | 764,871 | +110% | — | ||
| Sep 23, 202616:01 | Sep 22, 2026 | PHIOPhio Pharmaceuticals Corp. | Chairman, Pres. & CEO, Director | P · Buy | $1.03 | +2,000 | 364,871 | +1% | +$2K | -15.0% | -16.1% |
| Sep 15, 202616:00 | Sep 11, 2026 | PHIOPhio Pharmaceuticals Corp. | Chairman, Pres. & CEO, Director | F · Tax | $1.03 | −68,550 | 362,871 | -16% | $71K | ||
| Aug 19, 202616:01 | Aug 18, 2026 | PHIOPhio Pharmaceuticals Corp. | Chairman, Pres. & CEO, Director | P · Buy | $1.06 | +10,000 | 431,421 | +2% | +$11K | -7.0% | -18.6% |